June 25, 2018
PHILADELPHIA (Embargoed until 10 AM EDT, Monday, June 25, 2018) – Satoshi Minoshima, MD, PhD, professor and chair of the Department of Radiology and Imaging Sciences at the University of Utah, Salt Lake City, Utah, has assumed office as 2018-19 president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2018 Annual Meeting, June 23–26 in Philadelphia.
“As SNMMI president, I will vigorously pursue the second stage of SNMMI’s Value Initiative—Value Initiative 2.0,” Minoshima said. “We will advance our strong research and development efforts in theranostics, new biomarkers and instrumentation. We will support current and future value-focused practice of nuclear medicine and molecular imaging through creation of guidelines and care pathways. We will focus on advocacy to advance reimbursement strategies for our high-value patient care. We will strategize our future training pathways and promote our members’ leadership in the imaging and healthcare fields. We will continue our prolific outreach efforts to patients, referral communities and other stakeholders. And, we will promote diversity in workforce and leadership,” he asserted. “These goals are possible thanks to the huge talents and entrepreneurship among our SNMMI members and the strong support from industry, which help our value reach every patient.”
Minoshima earned his MD and PhD from Chiba University School of Medicine in Japan. Prior to his position at the University of Utah, Minoshima served on the faculty of the University of Michigan, as well as the University of Washington, where he was also vice chair for research in the Department of Radiology.
He has published seminal research studies concerning neurodegenerative diseases and other brain disorders using innovative imaging technology. His contributions to the field include discovery of the posterior cingulate abnormality in Alzheimer's disease and invention and worldwide dissemination of diagnostic statistical mapping technology for molecular brain imaging. Minoshima has served as president of the SNMMI Brain Imaging Council and as chair of the SNMMI Scientific Program Committee.
Minoshima’s recognitions include the Tetalman Memorial Award (1996) and Kuhl-Lassen Award (2006) from SNMMI and the Distinguished Scientist Award from the Western Regional SNM (2011). In collaboration with national and international members, he has created numerous initiatives for the SNMMI annual and mid-winter meetings. Minoshima has also contributed to a wide range of educational activities that advocate functional brain imaging and promote nuclear medicine and molecular imaging practice.
Other SNMMI officers elected for 2017-18 are Vasken Dilsizian, MD, Baltimore, Maryland, as president-elect and Alan B. Packard, PhD, Boston, Massachusetts, as vice president-elect. SNMMI Technologist Section officers for 2018-19 are Norman E. Bolus, MSPH, CNMT, FSNMMI-TS, Birmingham, Alabama, as the 2018-19 SNMMI-TS president and Mark H. Crosthwaite, MEd, CNMT, PET, FSNMMI-TS, Richmond, Virginia, as president-elect.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s more than 16,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.